Skip to main content

Advertisement

SpringerLink
Log in

Pineoblastoma is uniquely tolerant of mutually exclusive loss of DICER1, DROSHA or DGCR8

  • Correspondence
  • Published:
Acta Neuropathologica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. de Kock L, Sabbaghian N, Druker H, Weber E, Hamel N, Miller S et al (2014) Germ-line and somatic DICER1 mutations in pineoblastoma. Acta Neuropathol 128:583–595. https://doi.org/10.1007/s00401-014-1318-7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. de Kock L, Wu MK, Foulkes WD (2019) Ten years of DICER1 mutations: provenance, distribution, and associated phenotypes. Hum Mutat 40:1939–1953. https://doi.org/10.1002/humu.23877

    Article  CAS  PubMed  Google Scholar 

  3. Lee JC, Mazor T, Lao R, Wan E, Diallo AB, Hill NS et al (2019) Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma. Acta Neuropathol 137:851–854. https://doi.org/10.1007/s00401-019-01990-5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Li BK, Vasiljevic A, Dufour C, Yao F, Ho BLB, Lu M et al (2019) Pineoblastoma segregates into molecular sub-groups with distinct clinico-pathologic features: a Rare Brain Tumor Consortium registry study. Acta Neuropathol 139:223–241. https://doi.org/10.1007/s00401-019-02111-y

    Article  CAS  PubMed  Google Scholar 

  5. Liu APY, Gudenas B, Lin T, Orr BA, Jr Klimo P, Kumar R et al (2019) Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials. Acta Neuropathol 139:259–271. https://doi.org/10.1007/s00401-019-02106-9

    Article  CAS  PubMed  Google Scholar 

  6. Palculict TB, Ruteshouser EC, Fan Y, Wang W, Strong L, Huff V (2016) Identification of germline DICER1 mutations and loss of heterozygosity in familial Wilms tumour. J Med Genet 53:385–388. https://doi.org/10.1136/jmedgenet-2015-103311

    Article  CAS  PubMed  Google Scholar 

  7. Pfaff E, Aichmuller C, Sill M, Stichel D, Snuderl M, Karajannis MA et al (2019) Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterations. Acta Neuropathol 25:1–5. https://doi.org/10.1007/s00401-019-02101-0

    Article  CAS  Google Scholar 

  8. Pugh TJ, Yu W, Yang J, Field AL, Ambrogio L, Carter SL et al (2014) Exome sequencing of pleuropulmonary blastoma reveals frequent biallelic loss of TP53 and two hits in DICER1 resulting in retention of 5p-derived miRNA hairpin loop sequences. Oncogene 33:5295–5302. https://doi.org/10.1038/onc.2014.150

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Sabbaghian N, Hamel N, Srivastava A, Albrecht S, Priest JR, Foulkes WD (2012) Germline DICER1 mutation and associated loss of heterozygosity in a pineoblastoma. J Med Genet 49:417–419. https://doi.org/10.1136/jmedgenet-2012-100898

    Article  CAS  PubMed  Google Scholar 

  10. Sakaguchi M, Nakano Y, Honda-Kitahara M, Kinoshita M, Tanaka S, Oishi M et al (2019) Two cases of primary supratentorial intracranial rhabdomyosarcoma with DICER1 mutation which may belong to a "spindle cell sarcoma with rhabdomyosarcoma-like feature, DICER1 mutant". Brain Tumor Pathol 36:174–182. https://doi.org/10.1007/s10014-019-00352-z

    Article  CAS  PubMed  Google Scholar 

  11. Snuderl M, Kannan K, Aminova O, Dolgalev I, Heguy A, Faustin A et al (2015) Mb-17 * novel candidate oncogenic drivers in pineoblastoma. Neuro-Oncology 17:iii23. https://doi.org/10.1093/neuonc/nov061.93

    Article  PubMed Central  Google Scholar 

  12. Yates LR, Gerstung M, Knappskog S, Desmedt C, Gundem G, Van Loo P et al (2015) Subclonal diversification of primary breast cancer revealed by multiregion sequencing. Nat Med 21:751–759. https://doi.org/10.1038/nm.3886

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank Drs Anthony Liu, Annie Huang, Bryan Li, David Jones, and Elke Pfaff for providing additional data and clarifications.

Funding

WDF was funded by the Canadian Institutes of Health Research, Foundation Grant FDN-148390. BR received the support of a fellowship (LCF/BQ/PI19/11690009) from “laCaixa” Foundation (ID100010434) and from the Mia Neri Foundation and Cassa di Sovvenzioni e Risparmio fra il Personale della Banca d’Italia.

Author information

Authors and Affiliations

  1. Harry Perkins Institute of Medical Research, QEII Medical Centre, Centre for Medical Research, University of Western Australia, Perth, WA, Australia

    Leanne de Kock

  2. Program in Molecular Mechanisms and Experimental Therapy in Oncology (Oncobell), IDIBELL, Hospitalet de Llobregat, Barcelona, Spain

    Barbara Rivera

  3. Department of Human Genetics, McGill University, Montreal, QC, Canada

    William D. Foulkes

  4. Gerald Bronfman Department of Oncology, McGill University, Montreal, QC, Canada

    Barbara Rivera & William D. Foulkes

  5. Cancer Axis, Lady Davis Institute, Segal Cancer Centre, Jewish General Hospital, 3755 Côte-Sainte-Catherine Road, Montreal, QC, H3T 1E2, Canada

    Barbara Rivera & William D. Foulkes

  6. Cancer Research Program, Research Institute of the McGill University Health Centre, Montréal, QC, Canada

    William D. Foulkes

Authors
  1. Leanne de Kock
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barbara Rivera
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. William D. Foulkes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William D. Foulkes.

Ethics declarations

Conflict of interest

The authors have no conflicts of interest to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 660 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

de Kock, L., Rivera, B. & Foulkes, W.D. Pineoblastoma is uniquely tolerant of mutually exclusive loss of DICER1, DROSHA or DGCR8. Acta Neuropathol 139, 1115–1118 (2020). https://doi.org/10.1007/s00401-020-02139-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00401-020-02139-5

Search

Navigation